A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the standard CHOP-R regimen of Cyclophosphamide,
Doxorubicin, Vincristine, Prednisone, and Rituximab to CPOP-R (same regimen, but substituting
Doxorubicin with Pixantrone). The objective is to show that CPOP-R is not inferior to CHOP-R.